Alkermes to Take Part in the Citi Annual BioPharma Virtual Conference

<br /> Alkermes to Take Part in the Citi Annual BioPharma Virtual Conference<br />

PR Newswire

DUBLIN

,

Sept. 2, 2021

/PRNewswire/ —

Alkermes plc

(Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Citi 16
^th
Annual BioPharma Virtual Conference on

Thursday, Sept. 9, 2021

at

8:50 a.m. ET

(

1:50 p.m. BST

). The presentation may be accessed under the Investors tab on

www.alkermes.com

and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at

www.alkermes.com

.

Contact:

Alex Braun

Investor Relations

+1 781 296 8493